["{\n\"step_by_step_thinking\": \"The question is about avelumab's effectiveness for urothelial carcinoma. Since the provided documents are related to bladder cancer, I will look for information on monoclonal antibodies and their potential applications in treating bladder cancer. Specifically, I will search for any mentions of avelumab or similar agents. Based on the documents, I see that monoclonal antibodies are being explored as diagnostic and prognostic tools, and may have an impact on treatment. However, there is no specific mention of avelumab in these documents. Therefore, I cannot directly infer its effectiveness for urothelial carcinoma.\",\n\"answer_choice\": \"B: no\""]